Clin2
NCT06678867Possibly a fitNot yet recruiting

Glowing dye during surgery for children's brain tumours

Brain Tumor

Treatments studied

Part of Brain & nervous system, Cancer clinical trials.

This trial tests a drug called 5-ALA that makes brain tumor cells glow under a special light during surgery. This helps surgeons see and remove more of the tumor safely, potentially improving outcomes for children with high-grade brain tumors.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
3 years to 18 years
Study type
Interventional

Who can take part

  • Aged 3 to 18 years.
  • Have a high-grade brain tumor (either newly diagnosed or a return of ependymoma or high-grade glioma).
  • Tumor is located in the upper or lower back part of the brain, not in the brainstem.
  • Doctor has planned surgery to remove as much of the tumor as possible.
  • Good liver and kidney function, normal blood clotting, and normal blood pressure.
  • No personal or family history of porphyria (rare blood disorder causing light sensitivity), and no known sensitivity to light or to porphyrins.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04085887Recruiting· Phase 1/Phase 2
Uses a targeted dye to help find brain tumors during surgery

This early-stage trial tests whether an injected medicine with a glowing dye (panitumumab-IRDye800) can help doctors better see pediatric brain tumors during planned surgery. If it works, it may help surgeons remove more tumor tissue safely.

Stanford, California
NCT06160492Recruiting· Phase 3
Testing a Glowing Dye to Improve Brain Tumor Removal

This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.

Guangzhou, Guangdong
NCT06907485Not yet recruiting· Phase 2
5-ALA for pediatric brain tumor surgery

This trial tests whether a drug called 5-ALA (which helps surgeons see tumor cells more clearly during surgery) is safe and effective in children with certain brain tumors. It is given as a liquid before surgery, and the goal is to help the surgeon remove more of the tumor while protecting healthy brain tissue.

Chicago, Illinois
NCT07111182Recruiting
Using a Dye to Guide Brain Tumor Surgery

This study tests whether a special dye called 5-ALA can help surgeons see tumor tissue more clearly during brain tumor surgery. If you are having surgery for a high-grade glioma or another brain tumor, you may be able to join and help improve surgical precision.

Chicago, Illinois
NCT07609472Not yet recruiting· Phase 2
Glowing dye to help surgeons remove more brain tumor tissue

This trial tests a dye that makes brain tumor tissue glow under a special light during surgery, helping the surgeon see and remove more of the tumor while sparing healthy brain. It is for people with newly diagnosed high-grade glioma (a fast-growing brain tumor) who are scheduled for their first surgery to remove the tumor.

Miami, Florida
NCT07286903Recruiting
Fluorescence-guided brain tumor surgery study

This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.

Milan

Hear when a new Brain Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.